Child–Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies

Y Peng, X Qi, X Guo - Medicine, 2016 - journals.lww.com
Medicine Log in or Register Get new issue alertsGet alerts Secondary Logo Journal Logo
Advanced Search Toggle navigation Register Login Articles & Issues Browse by Specialty …

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

G D'Amico, G Garcia-Tsao… - Journal of …, 2006 - journal-of-hepatology.eu
1. Background Liver transplantation significantly improves the survival and quality of life of
patients with end-stage cirrhosis. However, a large proportion of cirrhotic patients still die …

EASL clinical practice guidelines: liver transplantation

European Association for The Study of the Liver - Journal of hepatology, 2016 - Elsevier
The first human orthotopic liver transplantation (LT) in Europe was performed by Sir Roy
Calne in Cambridge in 1968 [1], only one year after the first successful human liver …

Safety profile of autologous macrophage therapy for liver cirrhosis

F Moroni, BJ Dwyer, C Graham, C Pass, L Bailey… - Nature medicine, 2019 - nature.com
Therapies to reduce liver fibrosis and stimulate organ regeneration are urgently needed. We
conducted a first-in-human, phase 1 dose-escalation trial of autologous macrophage …

Liver cirrhosis

D Schuppan, NH Afdhal - The Lancet, 2008 - thelancet.com
Cirrhosis is defined as the histological development of regenerative nodules surrounded by
fibrous bands in response to chronic liver injury, which leads to portal hypertension and end …

Systematic review: the model for end‐stage liver disease–should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis?

E Cholongitas, GV Papatheodoridis… - Alimentary …, 2005 - Wiley Online Library
Background: Prognosis in cirrhotic patients has had a resurgence of interest because of liver
transplantation and new therapies for complications of end‐stage cirrhosis. The model for …

[PDF][PDF] A systematic review of the performance of the model for end‐stage liver disease (MELD) in the setting of liver transplantation

E Cholongitas, L Marelli, V Shusang… - Liver …, 2006 - Wiley Online Library
Abstract The Model for End‐Stage Liver Disease (MELD) score is now used for allocation in
liver transplantation (LT) waiting lists, replacing the Child‐Turcotte‐Pugh (CTP) score …

[HTML][HTML] The MELD score in patients awaiting liver transplant: strengths and weaknesses

M Bernardi, S Gitto, M Biselli - Journal of hepatology, 2011 - Elsevier
Adoption of the Model for End-stage Liver Disease (MELD) to select and prioritize patients
for liver transplantation represented a turning point in organ allocation. Prioritization of …

[PDF][PDF] Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial

PN Brennan, M MacMillan, T Manship, F Moroni… - Nature Medicine, 2025 - nature.com
Cirrhosis is a major cause of morbidity and mortality; however, there are no approved
therapies except orthotopic liver transplantation. Preclinical studies showed that bone …

Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B

YF Lou, MY Wang, WL Mao - PloS one, 2012 - journals.plos.org
Background Red blood cell distribution width (RDW), an automated measure of red blood
cell size heterogeneity (eg, anisocytosis) that is largely overlooked, is a newly recognized …